Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada

Harm Reduction Journal

Volumn 12, Issue 1, 2015, Pages

  Amlani, Ashraf ^a   McKee, Geoff ^b   Khamis, Noren ^b   Raghukumar, Geetha ^b   Tsang, Erica ^b   Buxton, Jane A ^a,b  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Fentanyl; Opioids; Overdose; People who use drugs; Survey

Indexed keywords

DIAMORPHINE; FENTANYL; METHAMPHETAMINE; NARCOTIC AGENT;

ADULT; AGE; ARTICLE; CANADA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG ABUSE; DRUG OVERDOSE; DRUG USE; FEMALE; GENDER; HEALTH SURVEY; HUMAN; MALE; PREVALENCE; QUESTIONNAIRE; URINALYSIS; BRITISH COLUMBIA; MIDDLE AGED; PROCEDURES; SUBSTANCE ABUSE; SUBSTANCE-RELATED DISORDERS; URINE; YOUNG ADULT;

ADULT; BRITISH COLUMBIA; CROSS-SECTIONAL STUDIES; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NARCOTICS; PREVALENCE; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84946945009     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/s12954-015-0088-4     Document Type: Article

References (21)

1. British Columbia Coroners Service. Information bulletin: BC Coroners Service warns of deaths related to illicit fentanyl use. 2014. http://www.pssg.gov.bc.ca/coroners/reports/docs/2014JAG0150-000766.pdf. Accessed 27 Oct 2015.
2. Canadian Centre on Substance Abuse, Canadian Community Epidemiology Network on Drug Use. CCENDU drug alert-increasing availability of counterfeit oxycodone tablets containing fentanyl. 2014. http://www.ccsa.ca/Resource%20Library/CCSA-CCENDU-Oxycontin-Fentanyl-Alert-2014-en.pdf Library/CCSA-CCENDU-Oxycontin-Fentanyl-Alert-2014-en.pdf. Accessed Oct 27, 2015.
3. Poklis A. Fentanyl: A Review for Clinical and Analytical Toxicologists. Clin Toxicol [Internet]. Informa UK Ltd UK; 1995;33(5):439-47. http://www.tandfonline.com/doi/abs/10.3109/15563659509013752?journalCode=ictx19#.VkU0cHGjN8E Accessed 11 May 2015.
4. Hess R, Stiebler G, Herz A. Pharmacokinetics of fentanyl in man and the rabbit. Eur J Clin Pharmacol [Internet]. 1972;4(3):137-41. http://link.springer.com/10.1007/BF00561135 Accessed 21 May 2015.
5. Jafari S, Buxton JA, Joe R. Rising fentanyl-related overdose deaths in British Columbia. Can J Addict. 2015;6(1):4-6. http://www.csam-smca.org/wp-content/uploads/2015/04/CJA-vol6-no1-2015.pdf. Accessed 27 Oct 2015.
6. Martin TL, Woodall KL, McLellan BA. Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004). J Anal Toxicol. 2006;30(8):603-10. http://jat.oxfordjournals.org/content/30/8/603.full.pdf. Accessed 11 May 2015.
7. Centers for Disease Control and Prevention. Nonpharmaceutical fentanyl-related deaths-multiple states, April 2005-March 2007. MMWR. 2008;57(29):793-6. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5729a1.htm. Accessed 12 May 2015.
8. Centers for Disease Control and Prevention. Acetyl fentanyl overdose fatalities-Rhode Island, March-May 2013. MMWR Morb Mortal Wkly Rep. 2013;62(34):703-4.
9. Canadian Centre on Substance Abuse. CCENDU bulletin: deaths involving fentanyl in Canada, 2009-2014. Ottawa, ON; 2015.
10. Kuo M, Shamsian A, Tzemis D, Buxton JA. A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012. Harm Reduct J. 2014;11:13.
11. Silverstein JH, Rieders MF, McMullin M, Schulman S, Zahl K. An analysis of the duration of fentanyl and its metabolites in urine and saliva. Anesth Analg. 1993;76:618-21.
12. BTNX Inc. Rapid response: fentanyl (FYL) test strip (urine) product insert. Markham, ON, Canada; 2013.
13. Sorge J, Buxton JA, Amlani A, Ishiguro S. Substance use trends in BC: a survey of harm reduction clients-overall results for British Columbia 2014. 2015.
14. Anonymous. Personal Communication. Vancouver; 2015.
15. Walsh J. Personal Communication. 2015.
16. Stiller RL, Scierka AM, Davis PJ, Ryan Cook D. A brief technical communication: detection of fentanyl in urine. Forensic Sci Int. 1990;44(1):1-6. http://www.sciencedirect.com/science/article/pii/037907389090160Z. Accessed 12 May 2015.
17. British Columbia Center for Disease Control. Communicating drug alerts (CDA)-tips for informing people who use drugs about adverse drug events. 2014.
18. Centers for Disease Control and Prevention. Community-based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(6):101-5.
19. Banjo O, Tzemis D, Al-Qutub D, Amlani A, Kesselring S, Buxton JA. A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. Can Med Assoc. 2014;2(3):E153-61. http://www.cmajopen.ca/content/2/3/E153.full. Accessed 26 May 2015. CMAJ Open.
20. A strategic plan for Rhode Island: RI Governor's Overdose Prevention and Intervention Task Force. 2015 http://www.strategicplanri.org/. Accessed 3 Nov 2015.
21. CDC Health Alert Network (HAN): increases in fentanyl drug confiscations and fentanyl-related overdose fatalities. Atlanta, GA; 2015 http://emergency.cdc.gov/han/han00384.asp. Accessed 3 Nov 2015.